MiR-34a promotes the expression of transforming growth factor-beta type 1 receptor (TβR1), TGF-β1 and p-SMAD2/3, which are connected to liver fibrosis and inflammatory cytokines such as interleukin-6 (IL-6) and IL-7 [13]. Here, IL6 is linked to Hepatic fibrosis.